IN THE KNOW: CYBG Merger Should Allow It To Swerve Margin Problems

Dow Jones

39,433.54

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
ETFs
UK
LSE
Ve Bionic Etf (CYBG)
Ve Bionic Etf (CYBG) News

Name	Symbol	Market	Type
Ve Bionic Etf	LSE:CYBG	London	Exchange Traded Fund

	Price Change	% Change	Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.049	0.28%	17.292	17.196	17.39				0	16:35:15

IN THE KNOW: CYBG Merger Should Allow It To Swerve Margin Problems

News) - Midcap lender CYBG PLC announced its interim results last Wednesday, giving investors a first look at how the ...

Subscribe now to see this Premium News article from

Alliance News Professional covers every UK stock in your portfolio. It goes beyond regulatory news and free web services to give your investment decisions an edge over the crowd.

Click for a FREE Trial

In The Know - Management and analyst comments that go beyond company announcements.
Flash headlines on all 2,400 London-listed companies before the news hits the open web.
Broker Ratings - The earliest tip-offs, many before the market opens.
Economic data and central bank flashes from UK, US and eurozone.
Taking AIM - Up to the minute market commentary on AIM stocks.
Over 500 news items per trading day for just £39.60 per month, and cancel at any time.

Try Alliance News FREE for 1 Month

Call us on +44 (0) 203 8794 460 to get started.